The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Eledon Pharmaceuticals Inc (NASDAQ: ELDN) closed the day trading at $2.26 down -7.38% from the previous closing price of $2.44. In other words, the price has decreased by -$7.38 from its previous closing price. On the day, 2.52 million shares were traded. ELDN stock price reached its highest trading level at $2.29 during the session, while it also had its lowest trading level at $2.11.
Ratios:
For a better understanding of ELDN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.41 and its Current Ratio is at 14.41. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 23, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELDN now has a Market Capitalization of 56077604 and an Enterprise Value of 5358674.
Stock Price History:
Over the past 52 weeks, ELDN has reached a high of $2.95, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is 21.14%, while the 200-Day Moving Average is calculated to be 44.38%.
Shares Statistics:
Over the past 3-months, ELDN traded about 101.75K shares per day on average, while over the past 10 days, ELDN traded about 139120 shares per day. A total of 24.21M shares are outstanding, with a floating share count of 22.85M. Insiders hold about 5.59% of the company’s shares, while institutions hold 38.19% stake in the company. Shares short for ELDN as of 1713139200 were 31133 with a Short Ratio of 0.31, compared to 1710460800 on 36360. Therefore, it implies a Short% of Shares Outstanding of 31133 and a Short% of Float of 0.15.
